Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Specifying ICD9, ICPC and ATC codes for the STOPP/START criteria: a multidisciplinary consensus panel.

de Groot DA, de Vries M, Joling KJ, van Campen JP, Hugtenburg JG, van Marum RJ, Vermeulen Windsant-van den Tweel AM, Elders PJ, van Hout HP.

Age Ageing. 2014 Jun 24. pii: afu075. [Epub ahead of print]

PMID:
24963101
[PubMed - as supplied by publisher]
2.

Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.

Boons CC, Swart EL, Timmers L, van de Ven PM, Janssen JJ, Hugtenburg JG.

BMC Cancer. 2014 Apr 8;14:247. doi: 10.1186/1471-2407-14-247.

PMID:
24712728
[PubMed - in process]
Free PMC Article
3.

Patient participation in medication reviews is desirable but not evidence-based: a systematic literature review.

Willeboordse F, Hugtenburg JG, Schellevis FG, Elders PJ.

Br J Clin Pharmacol. 2014 Apr 4. doi: 10.1111/bcp.12398. [Epub ahead of print]

PMID:
24698145
[PubMed - as supplied by publisher]
4.

Identification of drug-related problems of elderly patients discharged from hospital.

Ahmad A, Mast MR, Nijpels G, Elders PJ, Dekker JM, Hugtenburg JG.

Patient Prefer Adherence. 2014 Feb 4;8:155-65. doi: 10.2147/PPA.S48357. eCollection 2014.

PMID:
24523581
[PubMed]
Free PMC Article
5.

Adherence and patients' experiences with the use of oral anticancer agents.

Timmers L, Boons CC, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JN, Boven E, Hugtenburg JG.

Acta Oncol. 2014 Feb;53(2):259-67. doi: 10.3109/0284186X.2013.844353. Epub 2013 Nov 22.

PMID:
24266637
[PubMed - in process]
6.

The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.

Boons CC, VAN Tulder MW, Burgers JA, Beckeringh JJ, Wagner C, Hugtenburg JG.

Anticancer Res. 2013 Sep;33(9):3553-61. Review.

PMID:
24023280
[PubMed - indexed for MEDLINE]
7.

Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy.

Adhien P, van Dijk L, de Vegter M, Westein M, Nijpels G, Hugtenburg JG.

Int J Clin Pharm. 2013 Dec;35(6):1113-9. doi: 10.1007/s11096-013-9834-4. Epub 2013 Aug 13.

PMID:
23942987
[PubMed - in process]
8.

Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions.

Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L.

Patient Prefer Adherence. 2013 Jul 10;7:675-82. doi: 10.2147/PPA.S29549. Print 2013.

PMID:
23874088
[PubMed]
Free PMC Article
9.

Treatment inadequacy in primary and specialized care patients with depressive and/or anxiety disorders.

Bet PM, Hugtenburg JG, Penninx BW, Balkom Av, Nolen WA, Hoogendijk WJ.

Psychiatry Res. 2013 Dec 15;210(2):594-600. doi: 10.1016/j.psychres.2013.06.023. Epub 2013 Jul 11.

PMID:
23850429
[PubMed - in process]
10.

Side effects of antidepressants during long-term use in a naturalistic setting.

Bet PM, Hugtenburg JG, Penninx BW, Hoogendijk WJ.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1443-51. doi: 10.1016/j.euroneuro.2013.05.001. Epub 2013 May 30.

PMID:
23726508
[PubMed - indexed for MEDLINE]
11.

The use of capecitabine in daily practice: a study on adherence and patients' experiences.

Timmers L, Swart EL, Boons CC, Mangnus D, van de Ven PM, Peters GJ, Boven E, Hugtenburg JG.

Patient Prefer Adherence. 2012;6:741-8. doi: 10.2147/PPA.S36757. Epub 2012 Oct 19.

PMID:
23118530
[PubMed]
Free PMC Article
12.

Effect of a pharmacist medication review in elderly patients discharged from the hospital.

Ahmad A, Nijpels G, Dekker JM, Kostense PJ, Hugtenburg JG.

Arch Intern Med. 2012 Sep 24;172(17):1346-7. doi: 10.1001/archinternmed.2012.2816. No abstract available.

PMID:
22868274
[PubMed]
13.

Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early.

Menckeberg TT, Hugtenburg JG, Lammers JW, Raaijmakers JA, Bouvy ML.

Int J Clin Pharm. 2012 Apr;34(2):277-81. doi: 10.1007/s11096-012-9611-9.

PMID:
22287068
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008.

Timmers L, Beckeringh JJ, van Herk-Sukel MP, Boven E, Hugtenburg JG.

Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1036-44. doi: 10.1002/pds.2225. Epub 2011 Sep 29.

PMID:
21956857
[PubMed - indexed for MEDLINE]
15.

Discontinuation of statins among patients with type 2 diabetes.

Lamberts EJ, Nijpels G, Welschen LM, Hugtenburg JG, Dekker JM, Souverein PC, Bouvy ML.

Diabetes Metab Res Rev. 2012 Mar;28(3):241-5. doi: 10.1002/dmrr.1293.

PMID:
21898755
[PubMed - indexed for MEDLINE]
16.

Factors related to high and low levels of drug adherence according to patients with type 2 diabetes.

Borgsteede SD, Westerman MJ, Kok IL, Meeuse JC, de Vries TP, Hugtenburg JG.

Int J Clin Pharm. 2011 Oct;33(5):779-87. doi: 10.1007/s11096-011-9534-x. Epub 2011 Jul 7.

PMID:
21735249
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The use of erlotinib in daily practice: a study on adherence and patients' experiences.

Timmers L, Boons CC, Mangnus D, Moes JE, Swart EL, Boven E, Smit EF, Hugtenburg JG.

BMC Cancer. 2011 Jul 1;11:284. doi: 10.1186/1471-2407-11-284.

PMID:
21722354
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Long term patterns of use after initiation of oral antidiabetic drug therapy.

Lamberts EJ, Nijpels G, Welschen LM, Hugtenburg JG, Dekker JM, Souverein PC, Bouvy ML.

Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):351-8. doi: 10.1002/pds.2089. Epub 2010 Dec 23.

PMID:
21442684
[PubMed - indexed for MEDLINE]
19.

Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method.

van Leeuwen RW, Swart EL, Boven E, Boom FA, Schuitenmaker MG, Hugtenburg JG.

Ann Oncol. 2011 Oct;22(10):2334-41. doi: 10.1093/annonc/mdq761. Epub 2011 Feb 22.

PMID:
21343376
[PubMed - indexed for MEDLINE]
Free Article
20.

Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method.

van Leeuwen RW, Swart EL, Boom FA, Schuitenmaker MS, Hugtenburg JG.

BMC Cancer. 2010 Dec 13;10:679. doi: 10.1186/1471-2407-10-679.

PMID:
21144049
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk